Cargando…
Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status
BACKGROUND: Cerebrovascular diseases are common comorbidities in patients with cancer. Although active cancer causes ischemic stroke by multiple pathological conditions, including thromboembolism attributable to Trousseau syndrome, the relationship between stroke and inactive cancer is poorly known....
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751843/ https://www.ncbi.nlm.nih.gov/pubmed/34689573 http://dx.doi.org/10.1161/JAHA.120.021375 |
_version_ | 1784631762364661760 |
---|---|
author | Kikuno, Muneaki Ueno, Yuji Takekawa, Hidehiro Kanemaru, Kodai Shimizu, Takahiro Kuriki, Ayako Tateishi, Yohei Doijiri, Ryosuke Shimada, Yoshiaki Yamaguchi, Eriko Koga, Masatoshi Kamiya, Yuki Ihara, Masafumi Tsujino, Akira Hirata, Koichi Hasegawa, Yasuhiro Aizawa, Hitoshi Hattori, Nobutaka Urabe, Takao |
author_facet | Kikuno, Muneaki Ueno, Yuji Takekawa, Hidehiro Kanemaru, Kodai Shimizu, Takahiro Kuriki, Ayako Tateishi, Yohei Doijiri, Ryosuke Shimada, Yoshiaki Yamaguchi, Eriko Koga, Masatoshi Kamiya, Yuki Ihara, Masafumi Tsujino, Akira Hirata, Koichi Hasegawa, Yasuhiro Aizawa, Hitoshi Hattori, Nobutaka Urabe, Takao |
author_sort | Kikuno, Muneaki |
collection | PubMed |
description | BACKGROUND: Cerebrovascular diseases are common comorbidities in patients with cancer. Although active cancer causes ischemic stroke by multiple pathological conditions, including thromboembolism attributable to Trousseau syndrome, the relationship between stroke and inactive cancer is poorly known. The aim of this study was to elucidate the different underlying pathogeneses of cryptogenic stroke in active and inactive patients with cancer, with detailed investigation by transesophageal echocardiography. METHODS AND RESULTS: CHALLENGE ESUS/CS (Mechanisms of Embolic Stroke Clarified by Transesophageal Echocardiography for Embolic Stroke of Undetermined Source/Cryptogenic Stroke) registry is a multicenter registry including data of patients initially diagnosed as having cryptogenic stroke and undergoing transesophageal echocardiography. Patients were divided into active cancer, inactive cancer, and noncancer groups, and their clinical features were compared. Of the total 667 enrolled patients (age, 68.7±12.8 years; 455 men), 41 (6.1%) had active cancer, and 51 (7.5%) had a history of inactive cancer. On multinomial logistic regression analysis, infarctions in multiple vascular territories (odds ratio [OR], 2.73; 95% CI, 1.39–5.40) and CRP (C‐reactive protein) (OR, 1.10; 95% CI, 1.01–1.19) were independently associated with active cancer, whereas age (OR, 1.05; 95% CI, 1.01–1.08), contralateral carotid stenosis from the index stroke lesion (OR, 4.05; 95% CI, 1.60–10.27), calcification of the aortic valve (OR, 2.10; 95% CI, 1.09–4.05), and complicated lesion of the aortic arch (OR, 2.13; 95% CI, 1.11–4.10) were significantly associated with inactive cancer. CONCLUSIONS: Patients with cancer were not rare in cryptogenic stroke. Although patients with active cancer had more multiple infarctions, patients with inactive cancer had more atherosclerotic embolic sources potentially causing arteriogenic strokes. REGISTRATION: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000032957. |
format | Online Article Text |
id | pubmed-8751843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87518432022-01-14 Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status Kikuno, Muneaki Ueno, Yuji Takekawa, Hidehiro Kanemaru, Kodai Shimizu, Takahiro Kuriki, Ayako Tateishi, Yohei Doijiri, Ryosuke Shimada, Yoshiaki Yamaguchi, Eriko Koga, Masatoshi Kamiya, Yuki Ihara, Masafumi Tsujino, Akira Hirata, Koichi Hasegawa, Yasuhiro Aizawa, Hitoshi Hattori, Nobutaka Urabe, Takao J Am Heart Assoc Original Research BACKGROUND: Cerebrovascular diseases are common comorbidities in patients with cancer. Although active cancer causes ischemic stroke by multiple pathological conditions, including thromboembolism attributable to Trousseau syndrome, the relationship between stroke and inactive cancer is poorly known. The aim of this study was to elucidate the different underlying pathogeneses of cryptogenic stroke in active and inactive patients with cancer, with detailed investigation by transesophageal echocardiography. METHODS AND RESULTS: CHALLENGE ESUS/CS (Mechanisms of Embolic Stroke Clarified by Transesophageal Echocardiography for Embolic Stroke of Undetermined Source/Cryptogenic Stroke) registry is a multicenter registry including data of patients initially diagnosed as having cryptogenic stroke and undergoing transesophageal echocardiography. Patients were divided into active cancer, inactive cancer, and noncancer groups, and their clinical features were compared. Of the total 667 enrolled patients (age, 68.7±12.8 years; 455 men), 41 (6.1%) had active cancer, and 51 (7.5%) had a history of inactive cancer. On multinomial logistic regression analysis, infarctions in multiple vascular territories (odds ratio [OR], 2.73; 95% CI, 1.39–5.40) and CRP (C‐reactive protein) (OR, 1.10; 95% CI, 1.01–1.19) were independently associated with active cancer, whereas age (OR, 1.05; 95% CI, 1.01–1.08), contralateral carotid stenosis from the index stroke lesion (OR, 4.05; 95% CI, 1.60–10.27), calcification of the aortic valve (OR, 2.10; 95% CI, 1.09–4.05), and complicated lesion of the aortic arch (OR, 2.13; 95% CI, 1.11–4.10) were significantly associated with inactive cancer. CONCLUSIONS: Patients with cancer were not rare in cryptogenic stroke. Although patients with active cancer had more multiple infarctions, patients with inactive cancer had more atherosclerotic embolic sources potentially causing arteriogenic strokes. REGISTRATION: URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000032957. John Wiley and Sons Inc. 2021-10-23 /pmc/articles/PMC8751843/ /pubmed/34689573 http://dx.doi.org/10.1161/JAHA.120.021375 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Kikuno, Muneaki Ueno, Yuji Takekawa, Hidehiro Kanemaru, Kodai Shimizu, Takahiro Kuriki, Ayako Tateishi, Yohei Doijiri, Ryosuke Shimada, Yoshiaki Yamaguchi, Eriko Koga, Masatoshi Kamiya, Yuki Ihara, Masafumi Tsujino, Akira Hirata, Koichi Hasegawa, Yasuhiro Aizawa, Hitoshi Hattori, Nobutaka Urabe, Takao Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status |
title | Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status |
title_full | Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status |
title_fullStr | Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status |
title_full_unstemmed | Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status |
title_short | Distinction in Prevalence of Atherosclerotic Embolic Sources in Cryptogenic Stroke With Cancer Status |
title_sort | distinction in prevalence of atherosclerotic embolic sources in cryptogenic stroke with cancer status |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751843/ https://www.ncbi.nlm.nih.gov/pubmed/34689573 http://dx.doi.org/10.1161/JAHA.120.021375 |
work_keys_str_mv | AT kikunomuneaki distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT uenoyuji distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT takekawahidehiro distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT kanemarukodai distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT shimizutakahiro distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT kurikiayako distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT tateishiyohei distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT doijiriryosuke distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT shimadayoshiaki distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT yamaguchieriko distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT kogamasatoshi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT kamiyayuki distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT iharamasafumi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT tsujinoakira distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT hiratakoichi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT hasegawayasuhiro distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT aizawahitoshi distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT hattorinobutaka distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT urabetakao distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus AT distinctioninprevalenceofatheroscleroticembolicsourcesincryptogenicstrokewithcancerstatus |